You are viewing the comprehensive archive for articles tagged with "biotechnology." Our editorial team delivers timely artificial intelligence coverage, practical insights, and industry-focused analysis across the topics shaping how AI is built, funded, regulated, and adopted. This section brings together the most relevant news, research, and expert commentary to help you understand trends and make better technology decisions. Stay informed with AIstify to keep your perspective current and complete.
Recursion Pharmaceuticals is a biotechnology company known for industrialized biology, computational drug discovery, and clinical-stage therapeutic programs.
Insilico Medicine is a biotechnology company known for AI-enabled drug discovery platforms, generative chemistry, and therapeutic development.
Google DeepMind has introduced AlphaGenome, a new AI model designed to analyze long DNA sequences and predict how genetic variations may influence disease development.
AI coverage of health and biotechnology, tracking deployments, deals, and policy shaping care delivery, drug discovery, and biomedical research.
AstraZeneca has signed a $555 million milestone-based partnership with Algen Biotechnologies to deploy AI and CRISPR gene-editing together for immunology drug discovery.